HDFC Bank
TEPA.swiss
πŸ₯
India MedTech Hub

Medical Devices & Health Technology

India imports 70% of its medical devices. With 26.9% CAGR β€” the highest of all 22 tracked sectors β€” and a government target of USD 50B by 2030, this is the single largest opportunity for Swiss MedTech exporters.

95
USD 15.2B
Market 2025
+26.9%
CAGR
70%
Import Dep.
USD 50.1B
2030 Forecast
100%
FDI Allowed
95/100
Opp. Score
TEPA.swiss
TEPA.swiss MedTech Programme
Swiss MedTech companies get preferential India market access
EFTA–India TEPA: BCD 7.5–15% β†’ 0% by Year 5–7 (E5/E7 staging) Β· Regulatory support Β· Market entry guidance
Why India MedTech Now
πŸ“ˆ
Highest CAGR of 22 sectors
26.9% CAGR β€” outpacing pharma, IT, and consumer sectors. Driven by healthcare infrastructure expansion and rising income.
πŸ—οΈ
USD 50B Government Target
National Medical Devices Policy 2023 targets USD 50B sector by 2030. USD 400M PLI scheme for domestic manufacturing.
🌐
70% Import Dependency
India imports USD 8.6B in medical devices annually. Domestic production covers only 30% of demand β€” massive gap for Swiss exporters.
πŸ’Š
101M Diabetics, 63M Heart Patients
India's chronic disease burden drives demand for insulin delivery, cardiac devices, monitoring systems, and diagnostics.
πŸ₯
2M+ Medical Tourists Annually
India's medical tourism industry drives demand for world-class devices in Apollo, Fortis, and Manipal hospitals.
πŸ“±
Ayushman Bharat Digital Mission
Government's USD 1.6B digital health initiative creating demand for connected devices, telemedicine, and AI diagnostics.
Device Category Breakdown
CAGR by Category (%)
DiagnosticsSurgicalImplantsDigitalMedical09182736
πŸ”¬
Diagnostics & IVD+10.9% CAGRCDSCO B/C
In-vitro diagnostics, point-of-care testing, lab analyzers, reagents
USD 2.5B
β‚Ή21,000 Cr
Import Dependency65%
βš•οΈ
Surgical Instruments+11.7% CAGRCDSCO B/C
General surgical, laparoscopic, robotic surgery, electrosurgical units
USD 0.75B
β‚Ή6,300 Cr
Import Dependency55%
🦴
Implants & Orthopaedics+6.2% CAGRCDSCO C/D
Dental implants, orthopaedic implants, cardiac stents, spinal implants
USD 6.36B
β‚Ή53,424 Cr
Import Dependency80%
πŸ“±
Digital Health & AI+35% CAGRCDSCO A/B
Telemedicine platforms, AI diagnostics, wearables, remote patient monitoring
USD 14.5B
β‚Ή1.22 Lakh Cr
Import Dependency40%
πŸ₯
Medical Imaging+12.5% CAGRCDSCO C/D
MRI, CT scanners, ultrasound, X-ray, PET-CT systems
USD 2B
β‚Ή16,800 Cr
Import Dependency85%
CDSCO Regulatory Pathway
All medical devices imported into India require CDSCO import licence (Form MD-15) under Medical Devices Rules 2017. Foreign manufacturers cannot apply directly β€” an Authorized Indian Agent (AIA) is mandatory.
1
Classify Device1–2 weeks
Determine risk class: A (lowest) β†’ D (highest) under Medical Devices Rules 2017
Class A: General surgical, bandages, stethoscopes
Class B: Syringes, BP monitors, glucometers
Class C: Orthopaedic implants, ventilators, dialysis
Class D: Cardiac stents, HIV diagnostics, active implants
2
Appoint Indian Agent2–4 weeks
Mandatory: Foreign manufacturers must appoint a licensed Authorized Indian Agent (AIA)
AIA holds wholesale licence Form 20B/21B
AIA submits all applications to CDSCO
Power of Attorney required
AIA responsible for post-market compliance
3
Prepare Documentation4–8 weeks
Compile regulatory dossier for SUGAM portal submission
Free Sale Certificate / Certificate of Exportability
Device Master File & Site Master File
ISO 13485 Quality Certificate
Clinical data / performance evaluation
Label & IFU (Instructions for Use)
4
Submit on SUGAM Portal1 week
Online application via CDSCO SUGAM portal using Form MD-14
Paperless process since 2020
Government fees: USD 1,000–3,000/site + USD 50–1,500/device
Class A/B: β‚Ή5,000–10,000 fee
Class C/D: β‚Ή25,000–50,000 fee
5
CDSCO Review30 days – 18 months
CDSCO evaluates application; may issue queries requiring response
Class A/B: 30-day fast track
Class C/D: 6–18 months
New devices (no global approval): clinical investigation required
Devices with USFDA/CE Mark: expedited review
6
Receive Form MD-15Perpetual validity
Import licence issued under Form MD-15; valid perpetually with 5-year retention fee
Perpetual validity (5-year retention fee payment)
Same fee schedule for retention
Post-market surveillance obligations
Adverse event reporting to CDSCO
TEPA Regulatory Support
TEPA.swiss provides Swiss MedTech companies with regulatory guidance, Authorized Indian Agent referrals, and CDSCO application support. Contact TEPA for a free market entry consultation.
Contact TEPA.swiss
Swiss MedTech Advantage in India
Switzerland is the world's 4th largest medical device exporter (USD 15B+ annually). Swiss MedTech companies benefit from the EFTA–India TEPA agreement (EIF 2025), providing phased duty elimination on medical devices (HS Ch. 90) β€” BCD 7.5–15% reduced to 0% by Year 5–7 via E5/E7 staging categories. US and EU competitors continue to pay full MFN rates.
Phased Duty Elimination via TEPA
EFTA–India TEPA reduces BCD on medical devices (HS Ch. 90) from 7.5–15% to 0% by Year 5–7. US and EU competitors pay full MFN BCD + 5% Health Cess + 10% SWS throughout.
Swiss Quality Premium
Indian hospitals pay 15–25% premium for Swiss-made devices. 'Swiss Made' label commands highest trust in diagnostics, implants, and precision instruments.
CDSCO Fast Track for CE/USFDA
Devices with CE Mark or USFDA approval get expedited CDSCO review. Swiss devices typically hold CE Mark, enabling faster India market entry.
HDFC Bank Trade Finance
HDFC Bank provides Letters of Credit, Export Finance, and Trade Finance solutions for Swiss MedTech companies entering India. Preferred banking partner for TEPA members.
Swiss MedTech Companies in India
Roche Diagnostics
Basel, Switzerland
Diagnostics & IVD
Mumbai HQ; 18% IVD market share
PCR systems, immunoassay analyzers, cobas platform
TEPA member; EFTA-India FTA beneficiary
Straumann Group
Basel, Switzerland
Dental Implants
Bangalore office; 12% dental implant share
Dental implants, prosthetics, digital dentistry
TEPA member; expanding India dental network
Sonova
StΓ€fa, Switzerland
Hearing Aids & Audiological Devices
Delhi & Mumbai; Phonak brand leader
Hearing aids, cochlear implants, audiological devices
TEPA member; growing middle-class hearing health market
Ypsomed
Burgdorf, Switzerland
Drug Delivery / Insulin Devices
Partnership with Biocon; insulin pen systems
Insulin pens, autoinjectors, wearable injectors
India's 101M diabetics = massive opportunity
Hamilton Medical
Bonaduz, Switzerland
Ventilators & Critical Care
Post-COVID expansion; ICU ventilator leader
ICU ventilators, HAMILTON-C6, G5 series
TEPA member; government hospital procurement
Key Hospital Networks (End-Buyers)
Apollo Hospitals
10,209 beds
USD 200M+
annual device budget
Pan-India (Chennai, Delhi, Hyderabad, Mumbai, Bangalore +70 cities)
Import share: 65%Β·Multi-specialty; cardiac, oncology, transplants
Fortis Healthcare
4,800 beds
USD 80M+
annual device budget
Delhi NCR, Mumbai, Bangalore, Chandigarh, Kolkata
Import share: 60%Β·Cardiac, orthopaedic, neurology
Manipal Hospitals
9,000 beds
USD 120M+
annual device budget
Bangalore, Delhi, Goa, Mangalore, Vijayawada
Import share: 70%Β·Oncology, transplants, robotic surgery
Narayana Health
6,000 beds
USD 60M+
annual device budget
Bangalore, Kolkata, Ahmedabad, Delhi, Mysore
Import share: 55%Β·Cardiac surgery (world's lowest cost), oncology
Max Healthcare
3,500 beds
USD 70M+
annual device budget
Delhi NCR, Punjab, Uttarakhand
Import share: 65%Β·Oncology, cardiac, neuro, orthopaedic
AIIMS (Govt.)
2,500 beds
USD 150M+ (all AIIMS combined)
annual device budget
Delhi, Bhopal, Jodhpur, Rishikesh, Patna, Bhubaneswar
Import share: 75%Β·All specialties; government reference hospital
Via GeM portal: gem.gov.in
Enquire via TEPA
Indian MedTech Importer Directory
Verified Indian medical device importers and distributors. Data sourced from CDSCO licence registry, DGFT import data, and company filings. Click "Enquire via TEPA" to connect through TEPA.swiss trade facilitation.
12 importers found
Entero Healthcare SolutionsTEPA Fit: HIGH
Mumbai, MaharashtraTier 1
USD 180M+
annual turnover
Multi-category medical devices distribution
DiagnosticsSurgicalImplants
Clients: Apollo, Fortis, Kokilaben, Lilavati
India's largest healthcare distribution company; 3,500+ hospital clients
Genworks HealthTEPA Fit: HIGH
Bangalore, KarnatakaTier 1
USD 50M+
annual turnover
Diagnostic imaging & point-of-care devices
ImagingDiagnosticsDigital Health
Clients: Narayana Health, Manipal, KIMS, Aster
GE Healthcare's former India distribution partner; strong South India network
CPC DiagnosticsTEPA Fit: HIGH
Chennai, Tamil NaduTier 1
USD 30M+
annual turnover
IVD reagents, analyzers, laboratory equipment
DiagnosticsIVD
Clients: Apollo Chennai, MIOT, SRM, Fortis Malar
South India's leading IVD distributor; 500+ lab clients
Sandor MedicaidsTEPA Fit: HIGH
Hyderabad, TelanganaTier 1
USD 25M+
annual turnover
Orthopaedic implants, surgical instruments
ImplantsSurgical
Clients: KIMS, Yashoda, Care Hospitals, Continental
Telangana & AP specialist; strong government hospital relationships
Medequip IndiaTEPA Fit: HIGH
Delhi, Delhi NCRTier 1
USD 40M+
annual turnover
Critical care, ventilators, anaesthesia equipment
Critical CareImagingSurgical
Clients: AIIMS, Safdarjung, Max Healthcare, Medanta
Government hospital specialist; AIIMS preferred vendor for critical care
Trivitron HealthcareTEPA Fit: MEDIUM
Chennai, Tamil NaduTier 1
USD 200M+
annual turnover
Diagnostics, imaging, critical care β€” full portfolio
DiagnosticsImagingCritical Care
Clients: Pan-India; 3,000+ hospitals
India's largest home-grown MedTech company; also manufactures; strong import relationships
Nidek Medical IndiaTEPA Fit: MEDIUM
Ahmedabad, GujaratTier 1
USD 15M+
annual turnover
Ophthalmic equipment, laser systems
OphthalmologySurgicalDiagnostics
Clients: Aravind Eye, Sankara Nethralaya, LV Prasad
Ophthalmic device specialist; India's growing cataract surgery market
Skanray TechnologiesTEPA Fit: MEDIUM
Mysore, KarnatakaTier 2
USD 20M+
annual turnover
Imaging equipment, X-ray, C-arms
ImagingDiagnostics
Clients: Government hospitals, district hospitals
Manufactures and imports; strong government tender relationships
Poly MedicureTEPA Fit: MEDIUM
Faridabad, HaryanaTier 2
USD 80M+
annual turnover
Disposable medical devices, IV sets, catheters
ConsumablesCritical Care
Clients: Pan-India; exports to 100+ countries
Manufacturer + importer; Swiss partnerships for premium disposables
Healthium MedtechTEPA Fit: HIGH
Bangalore, KarnatakaTier 1
USD 120M+
annual turnover
Surgical sutures, wound care, advanced surgical devices
SurgicalWound Care
Clients: Pan-India; 5,000+ hospitals
Formerly Aesculap India (B.Braun); strong surgical device distribution network
Meril Life SciencesTEPA Fit: HIGH
Vapi, GujaratTier 2
USD 180M+
annual turnover
Cardiovascular, orthopaedic, endoscopy devices
ImplantsSurgicalDiagnostics
Clients: Pan-India; 4,000+ hospitals
Manufactures + imports; growing premium device portfolio; TEPA partnership potential
Sutures IndiaTEPA Fit: MEDIUM
Bangalore, KarnatakaTier 1
USD 35M+
annual turnover
Surgical sutures, wound closure, haemostats
SurgicalWound Care
Clients: Apollo, Fortis, Manipal, government hospitals
Premium surgical consumables; strong relationships with top-tier hospital chains
HDFC Bank
HDFC Bank Trade Finance
Banking solutions for Swiss MedTech exporters
Letters of Credit (LC) for medical device shipments
Export Finance & Pre-shipment credit
Foreign Currency Accounts for Swiss exporters
CDSCO registration fee remittance
Trade Finance for hospital procurement deals
Connect via TEPA.swiss
TEPA.swiss
Ready to Enter India's MedTech Market?
TEPA.swiss provides end-to-end market entry support
From CDSCO registration to distributor identification, hospital introductions, and trade finance β€” TEPA.swiss and HDFC Bank support Swiss MedTech companies at every step of India market entry.
Industry Events & Webinars

Key conferences, trade shows, and webinars for Swiss MedTech companies targeting India. TEPA-partnered events provide delegation support, B2B matchmaking, and regulatory briefings.

8 EVENTS FOUND
Featured
MEDICA 2026 β€” World Forum for Medicine
πŸ›οΈ Trade ShowπŸ‡¨πŸ‡­ TEPA Partner
Nov 16–19, 2026
DΓΌsseldorf, Germany
In-Person
83,000+
Organiser
Messe DΓΌsseldorf

World's largest medical trade fair. India Pavilion organised by TEPA.swiss β€” Swiss MedTech companies can exhibit under the Swiss national pavilion with TEPA support.

Why Attend
Global platform to meet Indian hospital procurement heads and distributors
DiagnosticsImagingSurgicalDigital Health
Register via TEPA
Featured
India MedTech Expo 2026
πŸ›οΈ Trade ShowπŸ‡¨πŸ‡­ TEPA Partner
Aug 12–15, 2026
Greater Noida, India
In-Person
30,000+
Organiser
Ministry of Health & Family Welfare, India

India's premier government-backed medical devices exhibition. TEPA.swiss organises the Swiss MedTech delegation. Direct access to CDSCO officials, hospital procurement teams, and Indian distributors.

Why Attend
Best event for Swiss companies seeking CDSCO guidance and Indian distributor meetings
All CategoriesCDSCOGovernment
Register via TEPA
Featured
TEPA MedTech India Market Entry Webinar
πŸŽ™οΈ WebinarπŸ‡¨πŸ‡­ TEPA Partner
Apr 10, 2026
Online
Webinar
200–400 per session
Organiser
TEPA.swiss

Quarterly webinar series for Swiss MedTech companies. Topics: CDSCO registration process, finding Authorized Indian Agents, TEPA duty benefits, and case studies from Roche, Straumann, and Ypsomed.

Why Attend
Free for TEPA members β€” ideal starting point for companies new to India
CDSCORegulatoryMarket Entry
Register via TEPA
Arab Health 2026
πŸ›οΈ Trade Show
Jan 26–29, 2026
Dubai, UAE
In-Person
55,000+
Organiser
Informa Markets

Middle East's largest healthcare exhibition β€” significant Indian buyer and distributor presence. Apollo, Fortis, and Narayana Health procurement teams regularly attend.

Why Attend
Meet Indian hospital procurement heads in a neutral international setting
ImagingDiagnosticsSurgical
View Event
CDSCO Regulatory Workshop β€” Medical Devices
🎀 Conference
May 22, 2026
New Delhi, India
In-Person
500+
Organiser
CDSCO / Ministry of Health

Annual CDSCO workshop on Medical Devices Rules 2017 updates, SUGAM portal improvements, and Class C/D approval timelines. Essential for regulatory affairs teams.

Why Attend
Direct engagement with CDSCO officials; understand latest regulatory changes
RegulatoryCDSCOClass C/D
View Event
Digital Health Summit India 2026
🎀 Conference
Sep 18–19, 2026
Bangalore, India
Hybrid
2,000+
Organiser
NATHEALTH

India's leading digital health conference. Covers AI diagnostics, telemedicine, wearables, and Ayushman Bharat Digital Mission implementation. Key event for Swiss digital health and IoMT companies.

Why Attend
Connect with Indian health-tech startups and hospital CIOs for digital health partnerships
Digital HealthAITelemedicine
View Event
Featured
Swiss MedTech India Trade Mission
πŸ‡¨πŸ‡­ TEPA EventπŸ‡¨πŸ‡­ TEPA Partner
Oct 6–10, 2026
Mumbai & Delhi, India
In-Person
15 Swiss companies
Organiser
TEPA.swiss / Switzerland Global Enterprise

Curated 5-day trade mission for Swiss MedTech companies. Includes B2B meetings with Indian distributors, hospital visits (Apollo, Fortis), CDSCO briefing, and HDFC Bank trade finance consultation.

Why Attend
Highest-ROI India market entry event for Swiss MedTech β€” limited to 15 companies
All CategoriesB2BTEPA Exclusive
Register via TEPA
NATHEALTH Healthcare Summit 2026
🎀 Conference
Nov 5–6, 2026
New Delhi, India
In-Person
1,500+
Organiser
NATHEALTH

India's premier healthcare industry summit. Brings together hospital CEOs, device manufacturers, regulators, and investors. Strong networking with Apollo, Fortis, and Max Healthcare leadership.

Why Attend
Senior-level networking with Indian healthcare decision-makers
HospitalsPolicyInvestment
View Event
All TEPA Events Calendar
View the full schedule of TEPA.swiss events, trade missions, and webinars for Swiss exporters to India.
TEPA Events Calendar
TEPA Intelligence Tools β€” MedTech
Compliance Checklist
HS 9018 Β· CDSCO MDR 2017 steps + EUR.1
Duty Calculator
HS 9018 Β· BCD 7.5% β†’ E7 saving
HS Code Finder
AI classifies your device instantly
Tariff Lookup
Browse all Ch. 90 concessions